Author:
Aubrey Brandon J.,Brunner Andrew M.
Funder
Novartis
National Institutes of Health
Biogen
AstraZeneca
Takeda Pharmaceuticals U.S.A.
Edward P. Evans Foundation
Janssen Pharmaceuticals
GlaxoSmithKline
Acceleron
Subject
Cancer Research,Oncology,Hematology
Reference75 articles.
1. The myelodysplastic syndromes: diagnosis and treatment;Steensma;Mayo Clin Proc,2006
2. NCCN Guidelines(R) Insights: Myelodysplastic Syndromes, Version 3.2022;Greenberg;J Natl Compr Canc Netw,2022
3. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology;Alessandrino;Haematologica,2002
4. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes;Bowen;Br J Haematol,2003
5. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献